AKAP 13 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of AKAP 13 monoclonal antibodies for research focused on understanding A-kinase anchoring protein 13. AKAP 13 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKAP 13, also known as A-kinase anchoring protein 13, plays a crucial role in the regulation of cellular signaling pathways by anchoring protein kinase A (PKA) and other signaling molecules to specific subcellular locations. This localization is vital for the precise modulation of various physiological processes, including cell growth, differentiation, and response to hormonal signals. The study of AKAP 13 has revealed significant implications in various diseases, including cancer and cardiovascular disorders. Researchers worldwide utilize AKAP 13 monoclonal antibodies to investigate cellular signaling mechanisms and their relationship to disease progression. Understanding AKAP 13's role in cell signaling continues to advance knowledge in both basic research and therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for AKAP 13 enable researchers to make meaningful contributions to scientific understanding of cellular signaling pathways and disease mechanisms.